DRCVX | RYCDX | DRCVX / RYCDX | |
Total Expense Ratio | N/A | N/A | - |
Annual Report Gross Expense Ratio | N/A | N/A | - |
Fund Existence | 39 years | 24 years | - |
Gain YTD | 3.535 | -30.708 | -12% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 1000 | 2500 | 40% |
Min. Initial Investment IRA | 250 | 1000 | 25% |
Net Assets | 6.78M | 13.8M | 49% |
Annual Yield % from dividends | 1.69 | 6.34 | 27% |
Returns for 1 year | 6.38 | -38.07 | -17% |
Returns for 3 years | 15.19 | -52.87 | -29% |
Returns for 5 years | 5.57 | -92.88 | -6% |
Returns for 10 years | -49.33 | -98.86 | 50% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
TEMRX | 8.10 | N/A | N/A |
Nuveen Emerging Markets Eq A | |||
GEBIX | 10.09 | -0.02 | -0.20% |
Goldman Sachs ESG Em Mkts Eq Inst | |||
FCLAX | 49.80 | -0.29 | -0.58% |
Fidelity Advisor Industrials A | |||
VYSVX | 23.25 | -0.16 | -0.68% |
Vericimetry US Small Cap Value | |||
UINQX | 51.24 | -1.26 | -2.40% |
Victory Nasdaq 100 Index Institutional |